SPINK7

SPINK7

Target · Serine protease inhibitor

SPINK7 Serine peptidase inhibitor Kazal type 7 · ECRG2

SPINK7 (serine peptidase inhibitor Kazal type 7, also known as ECG2 or ECRG2) is a secreted protein annotated as a probable serine protease inhibitor. It belongs to the Kazal-type serine peptidase inhibitor gene group. Browse Assay Genie's current range of SPINK7 research reagents below, or read on for the biology behind the target.

Secreted proteinProbable serine protease inhibitorKazal-type SPINK group
85 aa
Protein length
~9 kDa
Molecular weight
5q32
Gene locus
Kazal-type
Protein family
Target information

What is SPINK7 (serine peptidase inhibitor Kazal type 7)?

SPINK7 is described in UniProt as a probable serine protease inhibitor. Consistent with this, NCBI Gene reports that the protein is predicted to enable serine-type endopeptidase inhibitor activity and to be involved in the negative regulation of proteolysis. These assignments are predictions, so the SPINK7 protein is best studied with that context in mind.

The protein is secreted, and NCBI Gene predicts it to be active in the extracellular region. The human SPINK7 gene encodes a short protein, and the gene has orthologues named Spink7 in both mouse and rat, which allows comparative work in rodent models. Researchers may look for SPINK7 using an SPINK7 antibody or an SPINK7 ELISA kit, depending on the question being asked.

Beyond protease inhibition, SPINK7 is predicted to be involved in the inflammatory response and to act upstream of or within negative regulation of cytokine production involved in inflammatory response. The gene is classed by HGNC in the group of Kazal-type serine peptidase inhibitors. Its previous symbols are ECG2 and ECRG2, and an earlier gene name carried the qualifier 'putative', reflecting that its inhibitory role was inferred rather than firmly established. Related family members include SPINK1, SPINK4, SPINK5 and SPINK6.

Protease inhibitor biology

SPINK7 is a probable serine protease inhibitor, making it relevant to studies of serine-type endopeptidase inhibition.

Regulation of proteolysis

NCBI Gene predicts a role for SPINK7 in negative regulation of proteolysis in the extracellular region.

Inflammation research

SPINK7 is predicted to be involved in the inflammatory response, including negative regulation of inflammatory cytokine production.

Kazal-type family comparisons

As a member of the Kazal-type inhibitor group, SPINK7 supports comparative studies alongside other SPINK proteins and rodent Spink7 orthologues.

Background

SPINK7 frequently asked questions

What does SPINK7 do?

UniProt annotates SPINK7 as a probable serine protease inhibitor. NCBI Gene predicts it enables serine-type endopeptidase inhibitor activity, contributes to negative regulation of proteolysis, and acts in the extracellular region. These functions are predicted rather than fully characterised.

What other names does SPINK7 go by?

SPINK7 stands for serine peptidase inhibitor Kazal type 7. It has also been called ECG2 and ECRG2, and UniProt lists the protein as serine protease inhibitor Kazal-type 7. An earlier HGNC name carried the qualifier '(putative)'.

Is SPINK7 conserved across species?

Yes, orthologues named Spink7 are listed for both mouse and rat, so the gene can be studied in rodent models. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other Kazal-type serine peptidase inhibitors of the SPINK group with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P58062; product specifications from Assay Genie datasheets.

SPINK7 Product listing